dr. Mulya Rahma Karyanti, Sp.A(K), M.Sc, Ph.D
Investigator

- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Immunogenicity, and Efficacy of V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age
- Mortality in children with positive SARS-CoV-2 polymerase chain reaction test: Lessons learned from a tertiary referral hospital in Indonesia
https://www.sciencedirect.com/science/article/pii/S1201971221003301 - Dengue viral infection in Indonesia: Epidemiology, diagnostic challenges, and mutations from an observational cohort study
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0007785 - Diphtheria outbreak in Jakarta and Tangerang, Indonesia: Epidemiological and clinical predictor factors for death
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0246301 - Clinical Features of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 in Indonesia
https://academic.oup.com/tropej/article/68/3/fmac025/6565903